Skip to main content
Log in

Anti-hyperalgesic effects of imidazoline I2 receptor ligands in a rat model of inflammatory pain: interactions with oxycodone

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Emerging preclinical evidence suggests that imidazoline I2 receptor ligands may be effective analgesics. Quantitative analysis of the combined I2 receptor ligands and opioids is needed for the justification of combination therapy.

Objective

This study systematically examined the anti-hyperalgesic and response rate-suppressing effects of selective I2 receptor ligands (2-BFI and phenyzoline) alone and in combination with oxycodone in rats.

Methods

Von Frey filament test was used to examine the anti-hyperalgesic effects of drugs in a rat model of complete Freund’s adjuvant (CFA)-induced inflammatory pain. Schedule-controlled responding was used to assess the rate-altering effects of study drugs. Duration of actions of individual drugs (2-BFI, phenyzoline, and oxycodone) alone or in combination was studied. Dose-addition analysis was employed to assess the anti-hyperalgesic interactions between drugs.

Results

Oxycodone (0.1–3.2 mg/kg, i.p.), 2-BFI (1–17.8 mg/kg, i.p.), and phenyzoline (17.8–56 mg/kg, i.p.) all dose-dependently produced significant antinociceptive effects. When studied as combinations, 2-BFI and oxycodone produced additive interactions while phenyzoline and oxycodone produced supra-additive interactions under all fixed ratios. The same drug combinations did not alter or significantly reduced the operant responding depending on the ratios of the drug combinations.

Conclusions

Quantitative analysis of the anti-hyperalgesic effects of I2 receptor ligands strongly supports the therapeutic potential of I2 receptor ligands against inflammatory pain. In addition, the data reveal that phenyzoline is superior to the prototypic I2 receptor ligand 2-BFI for the management of pain and warrants further consideration as a novel analgesic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • An XF, Zhang Y, Winter JC, Li JX (2012) Effects of imidazoline I(2) receptor agonists and morphine on schedule-controlled responding in rats. Pharmacol Biochem Behav 101(3):354–359

    Article  CAS  PubMed  Google Scholar 

  • Berenbaum MC (1989) What is synergy? Pharmacol Rev 41(2):93–141

    CAS  PubMed  Google Scholar 

  • Boronat MA, Olmos G, Garcia-Sevilla JA (1998) Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands. Br J Pharmacol 125:175–185

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Diaz A, Mayet S, Dickenson AH (1997) BU224 produces spinal antinociception as an agonist at imidazoline I2 receptors. Eur J Pharmacol 333:9–15

    Article  CAS  PubMed  Google Scholar 

  • Escriba PV, Ozaita A, Garcia-Sevilla JA (1999) Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods. Ann N Y Acad Sci 881:8–25

    Article  CAS  PubMed  Google Scholar 

  • Ferrari F, Fiorentino S, Mennuni L, Garofalo P, Letari O, Mandelli S (2011) Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain. J Pain Res 4:111–125

    PubMed Central  CAS  PubMed  Google Scholar 

  • Gentili F, Cardinaletti C, Carrieri A, Ghelfi F, Mattioli L, Perfumi M, Vesprini C, Pigini M (2006) Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects. Eur J Pharmacol 553(1–3):73–81

    Article  CAS  PubMed  Google Scholar 

  • Gilron I, Jensen TS, Dickenson AH (2013) Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol 12(11):1084–1095

    Article  CAS  PubMed  Google Scholar 

  • Institute of Medicine (U.S.) (2011) Relieving pain in America: a blueprint for transforming prevention, care, education and research. National Academies Press, Washington, DC

    Google Scholar 

  • Ishihara M, Togo H (2007) Direct oxidative conversion of aldehydes and alcohols to 2-imidazolines and 2-oxazolines using molecular iodine. Tetrahedron 63(6):1474–1480

    Article  CAS  Google Scholar 

  • Jarry C, Forfar I, Bosc J, Renard P, Scalbert E, Guardiola B (1997) 5-(Arloxymethyl) oxazoline. US Patent 5,686,477, Adir eCompagnie

  • Koek W, Mercer SL, Coop A, France CP (2009) Behavioral effects of gamma-hydroxybutyrate, its precursor gamma-butyrolactone, and GABA(B) receptor agonists: time course and differential antagonism by the GABA(B) receptor antagonist 3-aminopropyl(diethoxymethyl) phosphinic acid (CGP35348). J Pharmacol Exp Ther 330(3):876–883

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lanza M, Ferrari F, Menghetti I, Tremolada D, Caselli G (2014) Modulation of imidazoline I2 binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats. Br J Pharmacol 171(15):3693–3701

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Li JX, Zhang Y (2011) Imidazoline I2 receptors: target for new analgesics? Eur J Pharmacol 658(2–3):49–56

    Article  CAS  PubMed  Google Scholar 

  • Li JX, Zhang Y (2012) Emerging drug targets for pain treatment. Eur J Pharmacol 681(1–3):1–5

    CAS  PubMed  Google Scholar 

  • Li JX, Crocker C, Koek W, Rice KC, France CP (2011a) Effects of serotonin 5-HT1A and 5-HT2A receptor agonists on schedule-controlled responding in rats: drug combination studies. Psychopharmacology (Berl) 213(2–3):489–497

    Article  CAS  Google Scholar 

  • Li JX, Zhang Y, Winter JC (2011b) Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I(2) receptor ligands. Eur J Pharmacol 669(1–3):59–65

    Article  CAS  PubMed  Google Scholar 

  • Li JX, Thorn DA, Qiu Y, Peng BW, Zhang Y (2014) Anti-hyperalgesic effects of imidazoline I2 receptor ligands in rat models of inflammatory and neuropathic pain. Br J Pharmacol 171(6):1580–1590

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Meregalli C, Ceresa C, Canta A, Carozzi VA, Chiorazzi A, Sala B (2012) CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats. J Pain Res 5:151–167

    PubMed Central  CAS  PubMed  Google Scholar 

  • Nagakura Y, Okada M, Kohara A, Kiso T, Toya T, Iwai A (2003) Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics. J Pharmacol Exp Ther 306(2):490–497

    Article  CAS  PubMed  Google Scholar 

  • Nutt DJ, French N, Handley S, Hudson A, Husbands S, Jackson H, Jordan S, Lalies MD, Lewis J, Lione L, Mallard N, Pratt J (1995) Functional studies of specific imidazoline-2 receptor ligands. Ann N Y Acad Sci 763:125–139

    Article  CAS  PubMed  Google Scholar 

  • Orrù A, Marchese G, Casu G, Casu MA, Kasture S, Cottiglia F et al (2014) Withania somnifera root extract prolongs analgesia and suppresses hyperalgesia in mice treated with morphine. Phytomedicine 21(5):745–752

    Article  PubMed  Google Scholar 

  • Qiu Y, He XH, Zhang Y, Li JX (2014) Discriminative stimulus effects of the novel imidazoline I2 receptor ligand CR4056 in rats. Sci Rep 4:6605

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Qiu Y, Zhang Y, Li JX (2015) Discriminative stimulus effects of the imidazoline I2 receptor ligands BU224 and phenyzoline in rats. Eur J Pharmacol 749:133–141

    Article  CAS  PubMed  Google Scholar 

  • Regunathan S, Reis DJ (1996) Imidazoline receptors and their endogenous ligands. Annu Rev Pharmacol Toxicol 36:511–544

    Article  CAS  PubMed  Google Scholar 

  • Sampson C, Zhang Y, Del Bello F, Li JX (2012) Effects of imidazoline I2 receptor ligands on acute nociception in rats. Neuroreport 23(2):73–77

    Article  CAS  PubMed  Google Scholar 

  • Sanchez-Blazquez P, Boronat MA, Olmos G, Garcia-Sevilla JA, Garzon J (2000) Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors. Br J Pharmacol 130(1):146–152

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Smith HS (2008) Combination opioid analgesics. Pain Physician 11(2):201–214

    PubMed  Google Scholar 

  • Tallarida RJ (2000) The composite additive curve. In: drug synergism and dose-effect data analysis. ed Tallarida, R.J.Chapman & Hall/CRC Boca Raton, pp 77–89

  • Thorn DA, Zhang Y, Peng BW, Winter JC, Li JX (2011) Effects of imidazoline I2 receptor ligands on morphine- and tramadol-induced antinociception in rats. Eur J Pharmacol 670(2–3):435–440

    Article  CAS  PubMed  Google Scholar 

  • Thorn DA, An XF, Zhang Y, Pigini M, Li JX (2012) Characterization of the hypothermic effects of imidazoline I2 receptor agonists in rats. Br J Pharmacol 166(6):1936–1945

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16(2):109–110

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Institute on Drug Abuse of the National Institutes of Health (Award no. R01DA034806) and by a grant from the National Natural Science Foundation of China (81373390). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun-Xu Li.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thorn, D.A., Siemian, J.N., Zhang, Y. et al. Anti-hyperalgesic effects of imidazoline I2 receptor ligands in a rat model of inflammatory pain: interactions with oxycodone. Psychopharmacology 232, 3309–3318 (2015). https://doi.org/10.1007/s00213-015-3983-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-015-3983-1

Keywords

Navigation